
Alembic Pharma passes Brazilian health regulator audit at Panelav API-II facility for eight APIs
Alembic Pharma Share Price | The Brazilian Health Regulatory Agency (ANVISA) GMP audit was conducted from September 16, 2024 to September 20, the company said.








